Zydus has got the final approval from the US Food and Drug Administration (USFDA) to market Icosapent Ethyl Capsules in strengths of 0.5 g and 1 g, it said in a regulatory filing. The capsules are indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia., Zydus has got the final approval from the US Food and Drug Administration (USFDA) to market Icosapent Ethyl Capsules in strengths of 0.5 g and 1 g, it said in a regulatory filing. The capsules are indicated as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way